A Phase II Study of Abraxane, Avastin and Gemcitabine for First Line Metastatic Breast Cancer

Trial Profile

A Phase II Study of Abraxane, Avastin and Gemcitabine for First Line Metastatic Breast Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 17 May 2017

At a glance

  • Drugs Paclitaxel (Primary) ; Bevacizumab; Gemcitabine
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2011 Interim results were presented at the 47th Annual Meeting of the American Society of Oncology (ASCO-2011).
    • 09 Dec 2008 Status changed from recruiting to active, no longer recruiting.
    • 06 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top